Jason Aryeh
Director at Ligand Pharmaceuticals Inc (LGND); Director at Orchestra BioMed Holdings, Inc. (OBIO)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return+18.0%
vs. S&P 500+12.4%
Beat the market100%
Paper profit on buys+$20K
Total bought / sold$37K / $1.2M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 12SEC | LGNDLigand Pharmaceuticals Inc | Sell | 500107,080 held (−0%) | $250.00 | $125K | +20.7% |
| Jun 12SEC | LGNDLigand Pharmaceuticals Inc | Sell | 4,500102,580 held (−4%) | $250.00 | $1.1M | +20.7% |
| May 20SEC | OBIOOrchestra BioMed Holdings, Inc. | Buy | 665118,118 held (+1%) | $3.75 | $2K | +58.7% |
| May 19SEC | OBIOOrchestra BioMed Holdings, Inc. | Buy | 8,971117,453 held (+8%) | $3.90 | $35K | +52.6% |
- Buy
Director Jason Aryeh bought $35K of OBIO at $3.90 — first open-market purchase in our records.